GB1116389A - Compositions for treatment of coccidiosis - Google Patents

Compositions for treatment of coccidiosis

Info

Publication number
GB1116389A
GB1116389A GB44047/66A GB4404766A GB1116389A GB 1116389 A GB1116389 A GB 1116389A GB 44047/66 A GB44047/66 A GB 44047/66A GB 4404766 A GB4404766 A GB 4404766A GB 1116389 A GB1116389 A GB 1116389A
Authority
GB
United Kingdom
Prior art keywords
methyl
amino
compositions
halogen
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB44047/66A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Schweiz AG
Original Assignee
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba AG filed Critical Ciba AG
Publication of GB1116389A publication Critical patent/GB1116389A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/116Heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00Preparation of halogenated hydrocarbons
    • C07C17/093Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/16Preparation of halogenated hydrocarbons by replacement by halogens of hydroxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/64Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C07D277/66Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2 with aromatic rings or ring systems directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Anticoccidiosis compositions comprise a quaternary 5 - ammonium - methyl - 4 - amino - 2 - R - pyrimidine salt, in which R represents a cycloaliphatic group optionally substituted by halogen, etherified hydroxy or mercapto groups and the ammonium nitrogen atom is part of a monocyclic or bicyclic hetercyclic radical optionally substituted by halogen, trifluoromethyl, hydroxy, alkoxy, mercapto and amino groups containing one or more double bonds, one of which extends from the ammonium nitrogen atom, and a carrier. The compositions are in the form of orally applicable, solid or liquid feedstuffs which may contain, besides conventional materials, other therapeutically useful substances, e.g. sulphonamides (examples given), antibiotics, e.g. penicillin, streptomycin, aureomycin, terramycin and tetracyclin, antiparasitic agents, e.g. methyl 4 - acetamino - 2 - ethoxy - benzoate, 2 - amino - 5 - nitrothiazole and 1 - (5 - nitro - 2 - thiazolyl) - 2 - oxo - tetrahydroimidazole, and/or tranquilizers, e.g. reserpine, methyl 18 - epi - O - methyl - reserpate and meprobamate.
GB44047/66A 1965-10-05 1966-10-03 Compositions for treatment of coccidiosis Expired GB1116389A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US49323365A 1965-10-05 1965-10-05
US53466666A 1966-03-16 1966-03-16
US57267166A 1966-08-16 1966-08-16
US592314A US3385857A (en) 1965-10-05 1966-11-07 Cycloaliphatic pyrimidines

Publications (1)

Publication Number Publication Date
GB1116389A true GB1116389A (en) 1968-06-06

Family

ID=27504357

Family Applications (2)

Application Number Title Priority Date Filing Date
GB44046/66A Expired GB1116388A (en) 1965-10-05 1966-10-03 Cycloaliphatic pyrimidines and process for their manufacture
GB44047/66A Expired GB1116389A (en) 1965-10-05 1966-10-03 Compositions for treatment of coccidiosis

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB44046/66A Expired GB1116388A (en) 1965-10-05 1966-10-03 Cycloaliphatic pyrimidines and process for their manufacture

Country Status (14)

Country Link
US (1) US3385857A (en)
AT (2) AT277653B (en)
BE (2) BE687778A (en)
BR (2) BR6683425D0 (en)
CH (1) CH484168A (en)
DE (1) DE1670389A1 (en)
DK (1) DK122326B (en)
FI (1) FI45115C (en)
FR (1) FR1503663A (en)
GB (2) GB1116388A (en)
IL (1) IL26554A (en)
NL (2) NL6613987A (en)
NO (1) NO122650B (en)
SE (1) SE331786B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3454575A (en) * 1967-03-06 1969-07-08 Ciba Geigy Corp Quaternary 5-ammonium-methyl-4-amino-2 cycloaliphatylpyrimidine salts
BE795071A (en) * 1972-02-08 1973-08-07 Merck & Co Inc COCCIDIOSTATIC COMPOUNDS
US4006143A (en) * 1974-04-09 1977-02-01 Merck & Co., Inc. Heterocyclic substituted pyrimidine compounds
US4044133A (en) * 1974-04-18 1977-08-23 Merck & Co., Inc. Anticoccidial compositions
US6077981A (en) * 1998-08-28 2000-06-20 Eastman Chemical Company Process for the production of cyclopropylmethyl halides
US6118032A (en) * 1999-08-03 2000-09-12 Eastman Chemical Company Process for the production of cyclopropylmethyl halides
EP1234508A1 (en) * 2001-02-21 2002-08-28 Universiteit Gent Antiprotozoal methods, compositions and feedstuffs
CN111760032B (en) * 2020-07-22 2022-02-25 广州白云山宝神动物保健品有限公司 Composition for preventing and treating drug-resistant coccidiosis of chicken and preparation method and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3042676A (en) * 1960-02-02 1962-07-03 Merck & Co Inc Pyridinium quaternary salts and methods of preparing the same

Also Published As

Publication number Publication date
AT281040B (en) 1970-05-11
US3385857A (en) 1968-05-28
FR1503663A (en) 1967-12-01
NO122650B (en) 1971-07-26
BR6683424D0 (en) 1973-12-04
CH484168A (en) 1970-01-15
GB1116388A (en) 1968-06-06
FI45115C (en) 1972-03-10
DE1670389A1 (en) 1970-11-05
DK122326B (en) 1972-02-21
BE687778A (en) 1967-04-04
BR6683425D0 (en) 1973-12-04
NL6613986A (en) 1967-04-06
AT277653B (en) 1970-01-12
NL6613987A (en) 1967-04-06
IL26554A (en) 1971-04-28
BE687779A (en) 1967-04-04
SE331786B (en) 1971-01-11
FI45115B (en) 1971-11-30

Similar Documents

Publication Publication Date Title
SE8700498D0 (en) NOVEL PHARMACEOLOGICALLY ACTIVE COMPOUNDS
NL149210B (en) PROCESS FOR THE PREPARATION OF POWDER COAT PREPARATIONS.
NL152286B (en) PROCESS FOR THE PREPARATION OF SELF-CROSSING POWDER COAT PREPARATIONS.
DK77981A (en) CEPHALOSPORIN DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF
IL40550A (en) Compositions for controlling plant-pathogenic organisms containing s-triazole(3,4-b) benzoxazole and benzothiazole derivatives and some new such derivatives
GB1116389A (en) Compositions for treatment of coccidiosis
ZA714210B (en) Tetrazolo(1,5-a)quinoline agents for the control of plant-pathogenic organisms
NL177689B (en) PHARMACEUTICAL PREPARATION FOR TREATING EFFECTS OF DIABETES, AND IMIDAZOLIDINE-2,5-DION-SPIRO (SIX-RING RING) COMPOUND.
NL151113B (en) PROCESS FOR THE PREPARATION OF POWDER COATING PREPARATIONS CONTAINING DIPHENOL-TYPE CROSSING AGENTS.
MX9203629A (en) MONOCLONAL ANTIBODIES COMPOSITIONS FOR THE PROPHYLACTIC OR THERAPEUTIC TREATMENT OF BACTERIAL INFECTIONS DUE TO GROUP B STREPTOCOCCES.
NL149211B (en) PROCESS FOR THE PREPARATION OF ACRYLIC GROUPS CONTAINING POWDER COATING PREPARATIONS USING TERTIARY NITROGEN COMPOUNDS.
NL149809B (en) PROCEDURE FOR THE PREPARATION OF COMPOUNDS SUITABLE FOR THE FLUOROMETRY, AND PROCEDURE FOR DETERMINING PRIMARY AMINO GROUPS CONTAINING COMPOUNDS THEREOF.
NL7605046A (en) PROCEDURE FOR PREPARING SEALING AND / OR COATING MASSES, AS WELL AS A PROCESS FOR SEALING AND FILLING JOINTS AND FOR COVERING SURFACES.
SE7511131L (en) TRIJODCARBANILATES
NL176563C (en) METHOD FOR THE PREPARATION OF A 2,4-DIAMINO-5- (3,4-METHYLENDIOXYBENZYL) PYRIMIDINE, AND A METHOD FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS USING SUCH A COMPOUND
NL7501413A (en) PROCESS FOR THE PREPARATION OF TITANIUM TRIHALO E COMPOUNDS.
IL43723A0 (en) New imidazo(2,1-b)thiazole derivatives,processes for the preparation thereof and pharmaceutical compositions containg them
NL156597B (en) PROCESS FOR THE PREPARATION OF COSMETIC PREPARATIONS, AS WELL AS FOR THE TREATMENT OF THEM, AND PROCESS FOR THE PREPARATION OF POLYCONDENSABLE COMPOUNDS.
CA945996A (en) Process for the preparation of 5-(4-aminobutyl)-hydantoin
SE9004169D0 (en) APPLICATION OF PHARMACEUTICAL AND COSMETIC COMPOSITIONS, CONTAINING 1,8-DIHYDROXY-10-PHENYL-9-ANTRON AS ACTIVE INGREDIENT
NL171888B (en) PROCESS FOR THE PREPARATION OF CYCLODODECATRIES- (1.5.9.).
NL159369B (en) PROCESS FOR THE PREPARATION OF ACARICIDE AND INSECTICIDE COMPOUNDS AND PREPARATIONS.
NL7414467A (en) PROCESS FOR THE PREPARATION OF 2,4-DIOXO-1-PY-RIMIDINYL PENICILIN AND CEPHALOSPORIN DERIVATIVES.
NL150775B (en) PROCEDURE FOR THE PREPARATION OF ACEETANILIDES WITH HERBICIDE ACTION AND PREPARATIONS CONTAINING SUCH COMPOUNDS.
IL39337A (en) 2-(pyridazinyl)-3-(4-methyl-piperazin-4-yl)carbonyloxy-isoindolin-1-one derivatives,processes for their preparation and pharmaceutical compositions containing the same